Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2095 of 5804
-
New Ultrasound-Based method could improve breast cancer diagnosis
Diagnosis CompletedThe purpose of this research is to conduct a clinical study to evaluate the efficacy of a noninvasive and quantitative tool for classification/diagnosis of breast masses. The main objective of this proposal is to test the SAVE (Sub-Hertz Analysis of Visco-Elasticity) method on a …
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Drug everolimus shows promise in slowing Children's brain tumors
Disease control CompletedThis is an open label study of everolimus in children with recurrent or progressive low-grade glioma.
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 26, 2026 14:47 UTC
-
New heart valve technology put to the test in 777 patients
Disease control CompletedThe objective of this trial is to confirm that the modifications to tissue processing, valve sterilization and packaging do not raise any new questions of safety and effectiveness in subjects who require replacement of their native or prosthetic aortic or mitral valve.
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for kids with hepatitis b: drug trial shows promise
Disease control OngoingThe primary objective of this study is to evaluate the antiviral efficacy of tenofovir disoproxil fumarate (tenofovir DF; TDF) versus placebo in pediatric population (aged 2 to \< 12 years at the time of enrollment) with chronic hepatitis B (CHB) infection.
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New liver cancer treatment shows promise in early trial
Disease control CompletedUnresectable, non-metastatic cirrhosis-related hepatocellular carcinoma (HCC) has a poor prognosis as there are no recommended curative treatments. Chemoembolisation is the most widely used treatment in these patients, but this technique can prove to be toxic. intrahepatic arteri…
Phase: PHASE1 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Pain device study tracks Real-World results for thousands
Disease control Recruiting nowTo compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use \- and - To evaluate the economic value and technica…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New MRI technique could help doctors Fine-Tune prostate cancer radiation in real time
Knowledge-focused OngoingProstate cancer is one of most common cancers in America, affecting 1 in 6 men. External beam radiation therapy is one of the common methods to treat prostate cancer. Although radiotherapy is effective, side effects to the adjacent normal organs limit the therapeutic ratio. Those…
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New support program aims to help cancer patients finish treatment and feel better
Symptom relief Recruiting nowThe purpose of this study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance)…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Mesh may stop hernias after colostomy
Prevention CompletedThe purpose of this study is to compare rates of hernia formation between colostomies created with no hernia preventing mesh versus colostomies created with a particular mesh.
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC
-
Can online parenting classes tame tough behavior?
Disease control CompletedThe research evaluates the use of online versions of delivering an effective psychological treatment for children clinically referred for serious oppositional, aggressive, and antisocial behavior. The goal is to develop models of delivery that reach families in need that are not …
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Brain aneurysm showdown: which treatment is safer and cheaper?
Disease control CompletedUnruptured saccular intracranial aneurysms larger than 7 mm can be treated with endovascular occlusion using detachable coils, with or without expendable stent assistance. A new endovascular technique has recently been developed, using flow diverter stents without associated coil…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can nicotine help protect kids from smoke?
Disease control CompletedThe overall aim of the current study is to determine if the use of nicotine containing products by caregivers who smoke and who are not interested in quitting, is effective in reducing children's secondhand smoke exposure.
Phase: NA • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Which antibiotic works best to prevent early labor in High-Risk pregnancies?
Disease control CompletedAbnormal vaginal flora is a risk factor for preterm labor. Therefore, in high risk pregnancies for preterm labor the diagnosis and treatment of abnormal flora is indicated. Clindamycin and metronidazole given orally are both acceptable treatments in these cases. The purpose of th…
Phase: NA • Sponsor: HaEmek Medical Center, Israel • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Lung cancer drug cocktail aims to extend life
Disease control CompletedThe primary objective of the study is to compare overall survival of participants randomized to receiving custirsen in combination with docetaxel with participants randomized to receive docetaxel alone.
Phase: PHASE3 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a common drug ease chronic stomach pain and nausea?
Symptom relief Recruiting nowThis phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the sto…
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
HPV vaccine shows promise for girls on Immune-Suppressing drugs
⭐️ VACCINE ⭐️ CompletedPRIMAVERA is a Phase IIa clinical trial, with the objective to assess the immunologic response to HPV vaccine in a population of immunocompromised girls. The principal hypothesis is that the immunologic response to tetravalent vaccine in girls who received immunosuppressive treat…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:36 UTC
-
Low-Dose rituximab shows promise for blood disorder
Disease control CompletedA comparative study with rituximab (100 mg weekly for 4 weeks and 375mg/m2 for once) shows low dose rituximab may be a useful alternative therapy in patients with ITP.The aim of this study is to compare the efficacy and tolerability of two different regimens of low doses rituxima…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New cancer drug shows promise in early trial
Disease control CompletedThe purpose of this study is to find a recommended dose level of LY3039478 that can safely be taken by participants with advanced cancer or cancer that has spread to other parts of the body, including but not limited to lymphoma. The study will also explore changes to various mar…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Heart rhythm breakdown? study tests everyday supplements for prevention
Prevention OngoingThe VITamin D and OmegA-3 TriaL (VITAL) is an ongoing randomized clinical trial of 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, hea…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Exercise may be the key to a longer life for seniors
Disease control OngoingHypothesis: Exercise will reduce morbidity and mortality rates in an elderly population. The extent of reduction will be intensity dependent.
Phase: NA • Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated Jun 26, 2026 17:02 UTC